Education
About Us
Working with TipRanks
Follow Us
MYND Life Sciences (TSE:MYND)
:MYND
MYND Stock Chart & Stats
C$0.07
-C$0.03(-30.00%)
At close: 4:00 PM EST
C$0.07
-C$0.03(-30.00%)
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.11
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$3.35M
Enterprise ValueC$4.85M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)$3.00M
Price to Earnings (P/E)―
Beta-0.37
Next Earnings
Sep 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding47,817,180
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.14
Price to Sales (P/S)0.00
P/FCF Ratio-3.58
Enterprise Value/Market Cap1.45
Enterprise Value/Revenue112.09
Enterprise Value/Gross Profit-77.99
Enterprise Value/Ebitda-3.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MYND Life Sciences News
MYND FAQ
What was MYND Life Sciences’s price range in the past 12 months?
MYND Life Sciences lowest stock price was C$0.03 and its highest was C$0.11 in the past 12 months.
What is MYND Life Sciences’s market cap?
MYND Life Sciences’s market cap is $3.35M.
When is MYND Life Sciences’s upcoming earnings report date?
MYND Life Sciences’s upcoming earnings report date is Sep 25, 2025 which is 84 days ago.
How were MYND Life Sciences’s earnings last quarter?
Currently, no data Available
Is MYND Life Sciences overvalued?
According to Wall Street analysts MYND Life Sciences’s price is currently Overvalued.
Does MYND Life Sciences pay dividends?
MYND Life Sciences does not currently pay dividends.
What is MYND Life Sciences’s EPS estimate?
MYND Life Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MYND Life Sciences have?
MYND Life Sciences has 47,817,180 shares outstanding.
What happened to MYND Life Sciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MYND Life Sciences?
Currently, no hedge funds are holding shares in TSE:MYND
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MYND Life Sciences
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. The company is headquartered in Kelowna, Canada.
Technical Analysis
Appili Therapeutics Inc Class A
―
HAVN Life Sciences
―
Glow LifeTech
―
Marvel Biosciences Corp
―
―